FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Unichem Pharmaceuticals Bisoprolol Fumarate and Hydrochlorothiazide Recall

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2

Unichem Pharmaceuticals USA Inc. · East Brunswick, NJ

Risk level
Class II
Reported by FDA
Feb 11, 2026
Recall ID
D-0301-2026
Check your lot numberHow we source this data

Summary

Unichem Pharmaceuticals recalled Bisoprolol Fumarate and Hydrochlorothiazide starting Jan 21, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0301-2026 on Feb 11, 2026. Reason: cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. Status: Ongoing.

Why it was recalled

cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

Product description

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01

Lot numbers, UPCs & expiration codes

Lot # GBHL24005A, Exp Date: 09/2026

Where it was sold

US Nationwide and PR.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0301-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jan 21, 2026
FDA report date
Feb 11, 2026
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Unichem Pharmaceuticals USA Inc.

Original FDA data

Every field from FDA enforcement report D-0301-2026, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Ongoing
Country
United States
Event ID
98323
Address
1 Tower Center Blvd Ste 2200
Code information
Lot # GBHL24005A, Exp Date: 09/2026
Postal code
08816-1145
Report date
Feb 11, 2026
Product type
Drugs
Recall number
D-0301-2026
Classification
Class II
Recalling firm
Unichem Pharmaceuticals USA Inc.
Reason for recall
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01
Distribution pattern
US Nationwide and PR.
Recall initiation date
Jan 21, 2026
Initial firm notification
Letter
Center classification date
Jan 30, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0301-2026, published Feb 11, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls